Stay updated on XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial

Sign up to get notified when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-17T20:39:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The record describes a Phase 1b trial of XMT-1592 for ovarian cancer and non-small cell lung cancer, including study eligibility, treatment arms, and outcome measures. It indicates the study was terminated because the development program was discontinued and is no longer recruiting.
    Difference
    44%
    Check dated 2026-11-10T16:46:20.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the study record page continues to show a 403 Forbidden error rather than trial details.
    Difference
    0.2%
    Check dated 2026-11-03T16:55:27.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A notice about NIH websites and terminology appears above the ClinicalTrials.gov 403 error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T16:35:23.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T17:32:43.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the detailed record. The trial information and navigation are no longer accessible, leaving only the site header and error message.
    Difference
    18%
    Check dated 2026-09-22T22:09:06.000Z thumbnail image

Stay in the know with updates to XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.